Atypical and Variable Clinical Presentation of Glutaric Aciduria Type I

We report atypical and variable clinical presentation of glutaric aciduria type I (GA I) in four children from two Greek families. In one family, a boy with typical biochemical and neuroradiological features of GA I suffered a metabolic crisis at 16 months of age resulting in a severe movement disorder. His sister, two years older and showing identical biochemical features, has remained neurologically normal throughout childhood and at six years of age is attending normal primary school. Both children are homozygous for P217 L, a novel missense mutation in exon 7 of the glutaryl-CoA dehydrogenase (GCDH) gene. In the other family, monozygotic twins presented at 6 years of age with mild developmental delay and a single episode of hypoglycaemia. Cranial magnetic resonance imaging (MRI) scans in both twins revealed almost identical high-signal alterations in the periventricular white matter and in the centrum semiovale. Biochemical analyses showed massive urinary excretion of glutaric and 3-hydroxyglutaric acids and carnitine depletion. Molecular studies showed compound heterozygosity for two novel putative null mutations, IVS6-1 G > A and Y413 X, in the GCDH gene. The milder clinical course of GA I in three of the four Greek patients demonstrates the phenotypic heterogeneity of the disease even within families. Asymptomatic siblings of GA I patients should always be investigated, and molecular studies may be useful for confirming the diagnosis, particularly when the presentation is atypical.

Key words

Glutaric aciduria type I - Glutaryl-CoA dehydrogenase deficiency - Mutation - Leukodystrophy - Dystonic tetraplegia - Asymptomatic - Monozygotic twins

References

• 1 Amir N, Elpeleg O, Shalev R S, Christensen E. Glutaric aciduria type I: clinical heterogeneity and neuroradiological features.  Neurology. 1987;  37 1654-1657
• 2 Anikster Y, Shaag A, Joseph A, Mandel H, Ben-Zeev B, Christensen E. et al . Glutaric aciduria type I in the Arab and Jewish communities in Israel.  Am J Hum Genet. 1996;  59 1012-1018
• 3 Baric I, Zschocke J, Christensen E, Duran M, Goodman S I, Leonard J V. et al . Diagnosis and management of glutaric aciduria type I.  J Inherit Metab Dis. 1998;  21 326-340
• 4 Dunger D B, Snodgrass G J. Glutaric aciduria type I presenting with hypoglycaemia.  J Inherit Metab Dis. 1984;  7 122-124
• 5 François B, Jaeken J, Gillis P. Vigabatrin in the treatment of glutaric aciduria type I.  J Inherit Metab Dis. 1990;  13 352-354
• 6 Goodman S I, Stein D E, Schlesinger S, Christensen E, Schwartz M, Greenberg C R. et al . Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I): review and report of thirty novel mutations.  Hum Mutat. 1998;  12 141-144
• 7 Haworth J C, Booth F A, Chudley A E, deGroot G W, Dilling L A, Goodman S I. et al . Phenotypic variability in glutaric aciduria type I: Report of fourteen cases in five Canadian Indian kindreds.  J Pediatr. 1991;  118 52-58
• 8 Hoffmann G F, Athanassopoulos S, Burlina A B, Duran M, De Klerk J BC, Lenehrt W. et al . Clinical course, early diagnosis, treatment and prevention of disease in glutaric-CoA dehydrogenase deficiency.  Neuropediatrics. 1996;  27 115-123
• 9 Hoffmann G F, Zschocke J. Glutaric aciduria type I: from clinical, biochemical and molecular diversity to successful therapy.  J Inher Metab Dis. 1999;  22 381-391
• 10 Ikeda H, Kimura T, Ikegami T, Kato M, Matsunaga A, Yokoyama S. et al . Novel mutations of the glutaryl-CoA dehydrogenase gene in two Japanese patients with glutaric aciduria type I.  Am J Med Genet. 1998;  80 327-329
• 11 Kölker S, Ahlemeyer B, Krieglstein J, Hoffmann G F. 3-hydroxyglutaric and glutaric acids are neurotoxic through NMDA receptors in vitro. .  J Inher Metab Dis. 1999;  22 228-232
• 12 Kyllerman M, Skjeldal O H, Lundberg M, Holme I, Jellum E, von-Dobeln U. et al . Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations.  Mov Disord. 1994;  9 22-30
• 13 Merinero B, Perez-Cerda C, Font L M, Garcia M J, Aparicio M, Lorenzo G. et al . Variable clinical and biochemical presentation of seven Spanish cases with glutaryl-CoA-dehydrogenase deficiency.  Neuropediatrics. 1995;  26 238-242
• 14 Morton D H, Bennett M J, Seargeant L E, Nichter C A, Kelley R I. Glutaric aciduria type I: a common cause of episodic encephalopathy and spastic paralysis in the Amish of Lancaster County, Pennsylvania.  Am J Med Genet. 1991;  41 89-95
• 15 Pineda M, Ribes A, Busquets C, Vilaseca M A, Aracil A, Christensen E. Glutaric aciduria type I with high residual glutaryl-CoA dehydrogenase activity.  Dev Med Child Neurol. 1998;  40 840-842
• 16 Renner C, Razeghi S, Uberall M A, Hartmann P, Lehnert W. Clinically asymptomatic glutaric aciduria type I in a 4 5/12-year-old girl with bilateral temporal arachnoid cysts.  J Inherit Metab Dis. 1997;  20 840-841
• 17 Schwartz M, Christensen E, Superti-Furga A, Brandt N J. The human glutaryl-CoA dehydrogenase gene: report of intronic sequences and of 13 novel mutations causing glutaric aciduria type I.  Hum Genet. 1998;  102 452-458
• 18 Ullrich K, Flott-Rahmel B, Schluff P, Musshof U, Das A, Luecke T. et al . Glutaric aciduria type I: pathomechanisms of neurodegeneration.  J Inher Metab Dis. 1999;  22 392-403
• 19 Yager J Y, McClarty B M, Seshia S S. CT-scan findings in an infant with glutaric aciduria type I.  Dev Med Child Neurol. 1988;  30 808-811
• 20 Zschocke J, Quak E, Guldberg P, Hoffmann G F. Mutation analysis in glutaric aciduria type I.  J Med Genet. 2000;  37 177-181